Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$166.66
4.072.5%
Last update: Oct 21, 4:00 PM
$166.66
4.072.5%
Guardant Health Inc (GH) Stock Price, Quote, News & History
GHNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Guardant Health (NASDAQ:GH) through any online brokerage.
Other companies in Guardant Health’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Labcorp Holdings Inc (NYSE:LH) and BrightSpring Health Services Inc (NASDAQ:BTSG).
Guardant Health has a consensus price target of $168.46.
The stock price for Guardant Health (NASDAQ: GH) is $166.66 last updated October 21, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Guardant Health.
Guardant Health does not have any upcoming earnings scheduled.
There is no upcoming split for Guardant Health.
Guardant Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
